Sponsor or institution
Clinical trials and research at Calcilytix Therapeutics, Inc., a BridgeBio company
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Calcilytix Therapeutics, Inc., a BridgeBio company that are recruiting, at sites in 3 countries (most in United States (2), Canada (1), United Kingdom (1)). By phase: Phase 3 (1), Phase 2/3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 3Countries
All recruiting trials (2)
-
Encaleret for Chronic Hypoparathyroidism: Testing if it helps symptoms and safety
This study tests whether taking encaleret pills can help people with chronic hypoparathyroidism, while being safe and tolerable.
-
Encaleret for children with autosomal dominant hypocalcemia type 1
This study tests whether encaleret is safe, how the body processes it, and if it helps newborns through 17-year-olds with ADH1.
Quick answers
How many clinical trials run by Calcilytix Therapeutics, Inc., a BridgeBio company are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in United States (2 trials), Canada (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 3: 1, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.